npr music

White House proposes to ‘march in’ on patents for costly drugs

To lower drug prices, the Biden administration is looking to assert its authority to license drug patents that rely on government-funded research to drugmakers that would offer cheaper medicines.

(Image credit: Anna Moneymaker/Getty Images)

Comment

Your email address will not be published. Required fields are marked *